Home/Filings/4/0001615219-23-000002
4//SEC Filing

Arthur David J. 4

Accession 0001615219-23-000002

CIK 0001615219other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 5:33 PM ET

Size

6.3 KB

Accession

0001615219-23-000002

Insider Transaction Report

Form 4
Period: 2023-01-03
Arthur David J.
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2023-01-03+20,00033,719 total
Holdings
  • Common Stock

    (indirect: By daughter)
    552
  • Common Stock

    (indirect: By son)
    564
Footnotes (1)
  • [F1]Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 25% of the shares of restricted stock will vest on January 2, 2024, and 1/36 of the remaining shares of restricted stock will vest on monthly anniversary thereafter.

Issuer

Salarius Pharmaceuticals, Inc.

CIK 0001615219

Entity typeother

Related Parties

1
  • filerCIK 0001769331

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:33 PM ET
Size
6.3 KB